» Authors » Marc Galimand

Marc Galimand

Explore the profile of Marc Galimand including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 794
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Perichon B, Bogaerts P, Lambert T, Frangeul L, Courvalin P, Galimand M
Antimicrob Agents Chemother . 2008 May; 52(7):2581-92. PMID: 18458128
Self-transferable IncFI plasmid pIP1206, isolated from an Escherichia coli clinical isolate, carries two new resistance determinants: qepA, which confers resistance to hydrophylic fluoroquinolones by efflux, and rmtB, which specifies a...
12.
Meziane-Cherif D, Lambert T, Dupechez M, Courvalin P, Galimand M
Antimicrob Agents Chemother . 2008 Jan; 52(4):1264-8. PMID: 18212108
Brachyspira pilosicoli BM4442, isolated from the feces of a patient with diarrhea at the Hospital Saint-Michel in Paris, was resistant to oxacillin (MIC > 256 microg/ml) but remained susceptible to...
13.
Perichon B, Courvalin P, Galimand M
Antimicrob Agents Chemother . 2007 May; 51(7):2464-9. PMID: 17470656
Plasmid pIP1206 was detected in Escherichia coli strain 1540 during the screening of clinical isolates of Enterobacteriaceae for high-level resistance to aminoglycosides. The sequence of this IncFI conjugative plasmid of...
14.
Bogaerts P, Galimand M, Bauraing C, Deplano A, Vanhoof R, De Mendonca R, et al.
J Antimicrob Chemother . 2007 Jan; 59(3):459-64. PMID: 17224412
Objectives: 16S rRNA methylase-mediated high-level resistance to aminoglycosides has been reported recently in clinical isolates of Gram-negative bacilli only from a limited number of countries. This study was conducted to...
15.
Galimand M, Carniel E, Courvalin P
Antimicrob Agents Chemother . 2006 Sep; 50(10):3233-6. PMID: 17005799
No abstract available.
16.
Liou G, Yoshizawa S, Courvalin P, Galimand M
J Mol Biol . 2006 Apr; 359(2):358-64. PMID: 16626740
Aminoglycosides are a medically important class of antibiotics used to treat serious infections. Methylation of the ribosomal target is an emerging mechanism that produces a high level of resistance to...
17.
Galimand M, Lambert T, Courvalin P
Euro Surveill . 2006 Mar; 10(1):E050127.2. PMID: 16556952
No abstract available.
18.
Radlinska M, Piekarowicz A, Galimand M, Bujnicki J
Pol J Microbiol . 2006 Feb; 54(3):249-52. PMID: 16450842
A recent study revealed a subfamily of N6-adenine (m6A) methyltransferases that comprises a few functionally studied eukaryotic members acting on mRNA and prokaryotic members acting on DNA as well as...
19.
Alonso R, Mateo E, Galimand M, Garaizar J, Courvalin P, Cisterna R
J Clin Microbiol . 2005 May; 43(5):2492-3. PMID: 15872292
Twenty-four community isolates of Streptococcus pyogenes resistant to ciprofloxacin and susceptible to levofloxacin, gatifloxacin, and moxifloxacin were studied. Sequence determination of the quinolone resistance-determining regions in the gyrA and parC...
20.
Alonso R, Galimand M, Courvalin P
J Antimicrob Chemother . 2004 Mar; 53(4):682-3. PMID: 15014061
No abstract available.